Korea Joongang Daily

Home > >

Vaccine diplomacy will help everyone

North Korea publicly declared the country was in an unprecedented crisis from the rapid spread of a contagious disease. The country has entered an emergency state and...

2022-05-16

Omicron is sweeping through North Korea

Almost 300,000 more people came down with symptoms of Covid-19 in North Korea as the country entered the fourth day of a draconian nationwide lockdown aimed at stopping its first officially acknowledged Covid-19 outbreak, according to state media.

2022-05-15

SK bioscience's typhoid vaccine approved for export

SK bioscience's typhoid vaccine was approved for export by the Ministry of Food and Drug Safety.

2022-05-13

North Korea admits its first Covid cases

North Korea has identified its first ever cases of Covid-19.

2022-05-12

Approval requested for Korea's first Covid vaccine

SK bioscience said Friday it applied with the Ministry of Food and Drug Safety for use approval for GBP510, its Covid-19 vaccine candidate.

2022-04-29

SK bioscience's GBP510 one step closer to being country's first vaccine

SK bioscience's Covid-19 vaccine candidate GBP510 demonstrated statistically meaningful results in Phase 3 trials, the company said Monday, bringing it one step closer to becoming the country's first homegrown Covid vaccine.

2022-04-25

New Covid infections drop below 100,000

New Covid-19 cases dropped below 100,000 Thursday as the Omicron wave continues to subside.

2022-04-21

Fourth vaccine doses offered to everyone over 59

Korea expanded the eligibility for fourth doses of Covid-19 vaccines to all people over the age of 59 starting Thursday.

2022-04-13

SK bioscience, IAVI hope to create nasal spray to prevent virus infections

SK bioscience teamed up with the International AIDS Vaccine Initiative (IAVI) and the University of Washington to work on developing a nasal spray that they hope will help prevent people from contracting the Covid-19 virus.

2022-04-13

SK bioscience looks to grow even as pandemic wanes

SK bioscience said it will continue to grow even as the pandemic wanes, using 5 trillion won ($4.1 billion) to 6 trillion won on merger and acquisitions (M&As) and developing variant-ready vaccines.

2022-03-31

What’s Popular Now